<DOC>
	<DOCNO>NCT00427141</DOCNO>
	<brief_summary>Studies GSK580416 complete rat dog . The main toxic effect see animal affect digestive system blood cell . Study OPS106400 first administration GSK580416 human . Parts A B study examine safety , tolerability , pharmacokinetics increase single dos GSK580416 reference placebo . Part C study ass effect food safety , tolerability , pharmacokinetics single dose GSK580416 healthy subject .</brief_summary>
	<brief_title>A Three-Part Study Of GSK580416 In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>Inclusion criterion : Healthy determine physician Healthy male female nonchild bear potential 18 55 year age ( inclusive ) Body weight &gt; = 50 kg BMI 19 30 kg/m2 ( inclusive ) Exclusion criterion : Positive HIV antibody , Hepatitis B surface antigen Hepatitis C antibody 3 month screen Male female subject willing follow study specify contraceptive method Subjects take recreational drug Regular use tobacco nicotinecontaining product within 6 month prior screen Has participate clinical trial receive drug within 30 day dose study drug Has expose 4 new chemical entity within 12 month first dose day Use prescription overthecounter medication within 7 day 5 halflives ( whichever longer ) prior first dose study drug Use St. John 's Wort within 28 day first dose study drug Subjects willing follow study specify life style restriction Blood donation excess 500 mL within 56 day period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>tolerability ,</keyword>
	<keyword>pharmacokinetics ,</keyword>
	<keyword>first time human ,</keyword>
	<keyword>food effect</keyword>
	<keyword>safety ,</keyword>
</DOC>